自創新藥 的英文怎麼說
中文拼音 [zìchuàngxīnyào]
自創新藥
英文
self-creating new medicine-
The center promotes interdisciplinary and international collaborative research with focus in functional genomics, exocrine physiology, reproductive biology, immunology and new drug development including tcm. the center has gained the support of nsfc, rockefeller foundation, the research grants council and it fund on a number of collaborating programmes
該中心提倡跨學科研究和國際合作，研究重點是與上皮相關的功能基因研究，外分泌生理學生殖生物學免疫學及藥物開發包括中草藥，並已獲國家自然科學基金委員會美國洛克菲勒基金會香港研究資助局創新科技署等支持開展多個合作項目。The natural science foundation of china ( " nsfc " ) has played a key role in promoting and supporting the center. the center promotes interdisciplinary and international collaborative research with focus in functional genomics, exocrine physiology, reproductive biology, immunology and new drug development ( including tcm ). the center has gained the support of nsfc, rockefeller foundation, the research grants council and it fund on a number of collaborating programmes
該中心提倡跨學科研究和國際合作，研究重點是與上皮相關的功能基因研究，外分泌生理學、生殖生物學、免疫學及藥物開發（包括中草藥） ，並已獲國家自然科學基金委員會、美國洛克菲勒基金會、香港研究資助局、創新科技署等支持開展多個合作項目。On the above research bases, we ? e proposed the optimized scheme of the raw material flow system of the production line, invented the high frequency vibrator and new type to prevent agglomeration store hopper. thus, we ? e fundamentally solved the problem of low screening efficiency and blocking in raw material flow
在此基礎上，提出了電焊條藥皮塗料自動配料成套生產線的物料流系統的優化設計方案，在技術和理論上都有所創新，成功研製了高效振動篩分機和新型防拱儲料倉，從根本上解決了篩分效率不高和物料流堵塞問題。Joint with several scientific institutes including fudan university school of life sciences, the company set up hengda new drug r & d center to make the most of universities, institutes and industry. with the platform of biochemistry, chemical synthesis and computer aided drug design, the center is committed to the development of novel medicines for the prevention and therapy of tumors, diabetes, hepatitis and aids. the mission is to discover and develop innovative drugs with full intellectual property held by chinese people
上海恆達科技發展股份有限公司自2000年以來聯合復旦大學生命科學學院等科研機構的各自優勢，創建並全力發展新藥研發平臺，打造了一個跨生物化學、計算機藥物輔助設計、化合合成三個學科的現代化藥物研發新平臺，目標是開發出中國人擁有自己知識產權的創新藥物，研究方向包括腫瘤、糖尿病、乙型肝炎、愛滋病等領域。Since its establishment, newbridge has invested in a variety of industries, including consumer food and beverage, semiconductor packaging and testing, port services, hotel and property management, steel, banking, software development / integration, telecom / communications, pharma and financial services
新橋投資自創立以來，新橋投資已投資涉足多個行業，包括餐飲業、半導體封裝及測試、港口服務、酒店和物業管理、鋼鐵、銀行、軟體開發/集成、電信/通訊、醫藥和金融服務。Innovation of tcm should be broken through strategy
中醫藥自主創新應從戰略上突破By utilizing " the theory on value chain ", the thesis advances that the strategic segment of the value chain in the bio - pharmaceutical industry is innovation of the bio - medical products, while the foothold of the product innovation lays on know - how researching and developing functional genes. thus the thesis proposes that under the premises of full understanding and grasping characteristics of the industry and corresponding products could investors give full play to their own advantages to date and collaborate the strong with mutual benefit meanwhile, investors would draw up purposeful investment strategy and build up flexible and effective guarantee system of investments. therefore, it would help the future investors not only to build up core competition capacity of their own in the long run, but also to grasp the investment opportunities more accurately, make their investment action more reasonable, lower the investment risks further and get richer return on investment
論文在對國內外生物醫藥行業發展現狀進行多方位分析、總結的基礎上，針對我國目前該行業中投資存在的「投資領域過于集中、投資者在思想認識、資金實力和投資方向方面與行業特點存在著較大的差距、風險投資環境尚未健全、運作管理相對滯后」等問題，利用「價值鏈理論」對該行業的投資機會加以分析，提出了「生物醫藥產業價值鏈的戰略環節為產品創新，而產品創新的立足點在於研發功能基因等專有技術」等觀點，建議投資者應在充分理解、把握生物醫藥行業及生物技術產品特點的前提下，根據目前自身的優勢，強強聯合、優勢互補，制定有針對性的投資戰略、配之靈活有效的投資保障體系，從而構建自身未來的核心競爭能力，以使未來此領域投資者的投資機會更準把握，投資行為更趨理智，投資風險更為降低，投資收益更加豐厚。Pharmaceutical industries in the western area should take the advantage of opportunities at home and abroad, and the self - superiority in natured resources to solve a series of problems including strategic recombination, structural development and pharmaceutical innovation as well as sustained development, to compete in seeking existence, development innovation, and to open up a new field for pharmaceutical economic development in west area
西部地區醫藥產業要充分利用目前有利的國際、國內環境，結合自身資源優勢，注意解決好戰略重組、結構調整、藥物創新、可持續性發展等一系列問題，在競爭中求生存、在競爭中求發展、在競爭中求創新，創出西部醫藥經濟發展的新天地。In order to cultivating pharmaceutical profession practical students with creative ability, we adopted " three steps " teaching strategy for advancing step by step in the teaching of organic chemistry experiment, finally, students independent experiment to help yourself came true, their ability also were improved to design experiment and solve practical question
為了培養具有創新能力的藥學專業實用型人才，在有機化學實驗教學中，採取從「抱著走」 、 「扶著走」到「自己走」的逐步放手和逐步提高的「三步式」教學策略，最終實現了學生自主式的自助實驗，提高了實驗設計能力和解決實際問題的能力。We should use this chance, establish an appropriate strategy and improve the innovation abilities of corporations. the long - term strategic target is to use about 10 years to complete the research for new medicines and then shift to " independent research and development " ; to be in the top level of the world for innovative research and development of new technology and new products in the biopharmaceutical industry ; to make china become the leading center for biotech innovation ; to set up an innovative mechanism with corporations to be the core body and relevant to the international competing situation and self developing disciplines of modern corporations ; to bring up a batch of entities with competing capacities in the market and independent exploitation abilities ; to be a leading country with great power in biotech industry. joint exploitation, improvement and innovation, dividing market into even smaller fractions, and cost minimization are the main conditions for realizing the strategic target
本論文從分析國內外生物技術企業的發展環境和發展特點入手，闡述我國生物技術企業加強科技創新的重要性和可行性，結合國情現狀研究我國生物技術企業的科技創新戰略，提出我國醫藥生物技術產業的長期戰略目標應該是「用十年左右的時間，完成新藥研究向"自主研發"的轉移，在新技術、新產品的創新性研發方面躋身世界醫藥生物技術產業的領先行列，將中國建設成為世界一流的生物技術創新中心，建立健全以企業為核心的適應國際醫藥競爭形勢和現代企業自身發展規律的技術創新運行機制體系，培養一批具有市場競爭力和自主開發能力的骨幹創新實體，成為世界生物技術產業強國" 。Explorations on self - reliance and creative development mode of teaching administration in higher education of chinese medicine
高等中醫藥教育教學管理自主創新發展模式探索分享友人